| Authors: |
Maharaj K; Department of Malignant Hematology.; Department of Immunology, and.; Department of Cancer Biology PhD Program, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Powers JJ; Department of Immunology, and., Achille A; Department of Immunology, and., Mediavilla-Varela M; Department of Malignant Hematology.; Department of Immunology, and., Gamal W; Department of Immunology, and.; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL., Burger KL; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Fonseca R; Department of Immunology, and., Jiang K; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Miskin HP; TG Therapeutics, Inc., New York, NY., Maryanski D; TG Therapeutics, Inc., New York, NY., Monastyrskyi A; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and., Duckett DR; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and., Roush WR; Department of Molecular Medicine, The Scripps Research Institute, Scripps Florida, Jupiter, FL., Cleveland JL; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sahakian E; Department of Malignant Hematology.; Department of Immunology, and., Pinilla-Ibarz J; Department of Malignant Hematology.; Department of Immunology, and. |